iPSCs : Recent Clinical Insights & Progress

iPSCs : Recent Clinical Insights & Progress

12 – 13 Nov 2026 | Paris, France

Home
Register
Register
Register
HomeAgendaCall for AbstractsSponsors & ExhibitorsPARTNERSRegistrationVenueFAQHow it works

iPSCs : Recent Clinical Insights & Progress

AGENDA PRE-PROGRAMME

📅 Day 1 – November 12, 2026

09:00 – 09:20
Registration & Welcome Coffee
09:20 – 09:30
Welcome Address – Prof. A. Bennaceur Griscelli

Session I – iPSC and Cancer Therapy & Models

09:30 – 10:15

Keynote Conference: IPSC-based NK-Cell Therapies in Cancer

Dan Kaufman, UCSD, San Diego, USA

10:20 – 11:30

Early Clinical Developments

10:20 – 10:40

iPSC-based Manufacturing and Immune Therapy Programs at CiRA

Dr Naosuke Nakamura, CIRA, Japan
10:40 – 11:00

iPSC-derived Macrophages and CAR Models

TBC
11:00 – 11:20

New paradigm for iPSC-based Cancer Vaccines

Frank Griscelli, Inserm Université Paris Cité, France
11:20 – 11:40 Coffee Break
11:45 – 12:30

Cancer iPSC Models & Drug Development

11:40 – 12:10

iPSC-based Cancer Organoids

Ali Turhan, Inserm University Paris Saclay, France
12:10 – 12:30

iPSC-based Drug Repurposing

TBC
12:30 – 14:00 Lunch & Sponsor Booth Visits

Session II – iPSCs and Regenerative Medicine

14:00 – 14:45

Keynote Conference: iPSC-Derived Models and Therapies in Cardiology : Introduction & Cardiac Organoid Models

Deepak Srivastava, Gladstone Institutes, USA

14:45 – 15:30

Keynote Conference: Clinical Trials using Heart Patches derived from iPSC

Keiichi Fukuda, HeartSeed, Japan

15:45 – 16:30 Coffee Break & Poster Session
16:30 – 17:30

iPSC-Based Therapies in Neurology & Ophthalmology

16:30 – 16:50

iPSC-derived Huntington Therapies

Jihwan Song, CHA Stem Cell Institute Seoul, South Korea
16:50 – 17:10

iPSC-based Huntington Models

Anselme Perrier, Inserm CEA, France
17:10 – 17:30

Pluripotent Stem Cell-Based Retinal Cell Therapies

Christelle Monville, University Evry, I-STEM, France
17:30 – 18:10

iPSC-Derived Preclinical Research

Short Talks
End of Day 1

📅 Day 2 – November 13, 2026

Session III – Novel Approaches in iPSC Manufacturing and Differentiation

09:00 – 09:45

Keynote Conference: Driving iPSC Fate Through Direct Nuclear Reprogramming

Alex Ng, GC Therapeutics, USA

09:45 - 10:05

Safety, Consistency & Manufacturing

09:45 – 10:05

LNP-RNA Technology for iPSC Generation

UbriGen
10:05 – 10:25

Manufacturing iPSC-Derived NK Cells

Boris Greber, Catalent, Germany
10:25 – 11:00 Coffee Break
11:00 – 11:40

European cGMP iPSC Landscape

HaploiPSC Program in Europe

Anna Veiga, Institut d'Investigació Biomèdica de Bellvitge. IDIBELL, Spain

EU hPSC Registry

TBC

Comprehensive Genomic-landscape of cGMP iPSC and engineered cells

Annelise Bennaceur Griscelli, CiTHERA, France

International iPSC QC assessment rounds

TBC on Behalf of GAIT

11:40 – 12:30

Manufacturing iPSC Technologies

Sponsored Innovation Showcase Presentations
12:30 – 14:00 Lunch & Sponsor Booth Visits

Session IV – Novel iPSC-Derived Cell Therapy Products & Technologies

14:00 – 14:45

Keynote Conference: Chemical Reprogramming and ciPSC-Derived Islets for Diabetes Therapy

Hongkui Deng, Beijing University, China

14:45 – 15:05

Landscape of hESC vs hiPSC Clinical Trials in 2026

Glyn Stacey, International Stem Cell Banking Initiative, UK (tbc)

15:05 – 15:45

iPSC-Based Preclinical Programs

Short talks
15:45 – 16:15 Coffee Break
16:15 – 17:15

iPSC Technology: Differentiation, Maturation and Beyond

Short talks
17:15 Closing Remarks

SCIENTIFIC ADVISORY BOARD

The Agenda has been setup by the Scientific Advisory Board composed of the following Experts :

Prof. Annelise Bennaceur Griscelli

Professor Hematology at Paris Saclay University, France
Director of CiTHERA, **The Center for iPS Cell Therapies
**Coordinator of The National iPSC Infrastructure INGESTEM,
Group Leader at INSERM U1310, France

Prof. Ali Turhan

Professor of Hematology
Paris Saclay University
Director of Clinical iPSC Program at CiTHERA, and National Pluripotent Stem Cell Infrastructure INGESTEM,
Group Leader at INSERM U1310, France

Prof. Anna Veiga

Director of the Barcelona Stem Cell Bank
Group leader at Pluripotent Stem Cell Therapy research group at the Regenerative Medicine Program (REGENBELL) at Institut d’ Investigació Biomèdica de Bellvitge (IDIBELL), Spain

Dr. Glyn Stacey

Professor at the Universities of Bedfordshire and Suffolk,UK
Institute of Stem Cell and Regeneration, CAS, Beijing, China

Dr. Anselme L. Perrier

Research Director at INSERM
Group leader at the CEA/CNRS U9199  Laboratory of Neurodegenerative Diseases,MIRCEN Infrastructure, France